Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other solid neoplasm 1Gynecologic 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Neoplasm Metastasis 9Colorectal Neoplasms 8Rectal Neoplasms 7Liver Neoplasms 7Carcinoma, Hepatocellular 7Colonic Neoplasms 6Rhabdomyosarcoma 4Hepatoblastoma 4Wilms Tumor 3Sarcoma, Ewing 3Sarcoma 3Rhabdoid Tumor 3Retinoblastoma 3Neuroblastoma 3Melanoma 3Medulloblastoma 3Central Nervous System Neoplasms 3Carcinoma, Renal Cell 3Uveal Melanoma 2Pancreatic Neoplasms 2Neoplasms, Germ Cell and Embryonal 2Neoplasms 2Kidney Neoplasms 2Hyperthermia 2Carcinoma, Islet Cell 2Brain Neoplasms 2Astrocytoma 2Appendiceal Neoplasms 2Vipoma 1Testicular Neoplasms 1

Interventions

repotrectinib 1pralsetinib 1lutetium Lu 177 dotatate 1copper dotatate CU-64 1cixutumumab 1Thiotepa 1Sunitinib 1Peripheral Blood Stem Cell Transplantation 1Melphalan 1Lutetium-177 1Lutetium 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Busulfan 1Bone Marrow Transplantation 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuroectodermal Tumors × Melphalan × Gastrointestinal × Clear all
NCT00003926 2017-11-29

Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors

Masonic Cancer Center, University of Minnesota

Phase 1 Terminated
13 enrolled
CNSGastrointestinalGenitourinaryGynecologicOther solid neoplasmSarcoma

Ovarian Germ Cell Cancer, Astrocytoma, Brain Neoplasms, Chordoma, Ependymoma, Glioma, Kidney Neoplasms, Liver Neoplasms, Medulloblastoma, Wilms Tumor, Neuroblastoma, Ovarian Neoplasms, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Teratoma, Testicular Neoplasms, Central Nervous System Neoplasms, Neuroectodermal Tumors, Hepatoblastoma, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡